Healthcare Management News - SEC chief recused from Frist HCA stock sale probe

WASHINGTON, Sept 26 (Reuters) - Christopher Cox, chairman of the U.S. Securities and Exchange Commission, said on Monday he will recuse himself from any SEC probe of sales of stock in hospital company HCA Inc. (

http://c.moreover.com/click/here.pl?r397010872